![]() |
MRI of the brain shows a 4.5 x 3.5 cm soft tissue mass in the pineal region. The mass appears slightly hypointense to parenchyma on T1-weighted images (Image 1, with arrow) and isointense to grey matter on T2-weighted images (Images 2 and 3, with arrows). There is relatively homogeneous enhancement of the mass following contrast administration with a central focal area of hypointensity (Images 4 and 5, arrows), most likely representing cystic necrosis. The mass (arrows) extends superiorly into the splenium of the corpus callosum (short black arrow), anteriorly into the quadrigeminal plate in the midbrain (short white arrow), and inferiorly into the vermis of the cerebellum (long white arrow).
MRI depicts these masses as large, lobulated, generally solid tumors with areas of cystic necrosis. The signal characteristics vary, but in general pineoblastomas are essentially isointense to grey matter on both T1 and T2-weighted images. The tumors enhance homogeneously with contrast. These signal characteristics are seen in other primitive neuroectodermal tumors (PNET) and are probably related to scant cytoplasm and overall dense cellularity of these tumors. The prognosis for patients with pineoblastomas is generally poor.
2. Atlas S. Magnetic resonance imaging of the brain and spine. 1st ed. New York, Raven Press, 1991:296-298.
Dear Visitors: Nothing on this World Wide Web site should be considered medical advice. Only your own doctor can help you make decisions about your medical care. It is not the policy of the Brigham and Women's Hospital Department of Radiology to provide consultation on the World Wide Web or via e-mail. If you have a specific medical question or are seeking medical care, please call the Brigham and Women's Hospital toll-free physician referral line at 1-800-294-9999.
Is this a mirrored page?
The official homepage of the BrighamRAD Teaching Case Database is http://brighamrad.harvard.edu/education/online/tcd/tcd.html
Contact the BrighamRAD Design Team for additional information about this website.